Last reviewed · How we verify

NCT05075629

Anxiety, Depression and Substance Use in Undergraduate Health Science Students During the Covid-19 Pandemic.

Completed Last updated 20 April 2023
What this trial tests

trial in Depression in 384 participants. Completed in 31 March 2022.

Timeline
12 October 2021
Primary endpoint
14 October 2021
31 March 2022

Quick facts

Lead sponsorUniversidad Westhill, Facultad de Psicología
StatusCompleted
Study typeOBSERVATIONAL
Enrollment384
Start date12 October 2021
Primary completion14 October 2021
Estimated completion31 March 2022
Sites1 location across Mexico

Conditions studied

Sponsor

Universidad Westhill, Facultad de Psicología

Who can join

Adults 18 to 64, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study will be conducted with a quantitative approach with correlational scope, observational analytical study, prospective cross-sectional. The objective is to compare the levels of anxious symptomatology, depressive symptomatology and substance use in university students who were exposed to SARS-CoV-2 with those who were not.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Universidad Westhill, Facultad de Psicología trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05075629.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing